ERBB2 and ductal breast carcinoma in situ: In DCIS, several clinicopathological features have been associated with a higher risk of local recurrence, including large lesion size, high nuclear grade (grade III), presence of comedonecrosis, positive surgical margins, high stromal TIL density, and HER2-positive or triple-negative molecular subtypes [1,2,32].